Meet the Team – Governance

Danny DjurasevichDipPharm

Director / Co-Founder

With more than 40 years’ experience as a pharmacist and pharmacy owner, Danny brings significant commercial and strategic experience in the healthcare sector.

Through his pharmacy which he founded, CPIE Pharmacy Services (CPIE), he established the R&D company Infusion Innovations which is designing and commercialising medical technologies, including the Scarab® infusion pump.

Danny is a director and board member of several companies in hospitality, healthcare, retail and manufacturing industries.

Andrew Sluggett BPharm BSc (Hons) Dip Mgt FPS MAICD

Managing Director / Co-Founder

Andrew has acquired a broad range of skills and experience in both the hospital and community settings, including, clinical pharmacist, accredited pharmacist, and cytotoxic/sterile manufacturing. His achievements led him to being awarded the South Australian Pharmacist of the year (2014) and Young Hospital Pharmacist of the year (2015).

As GM/Chief Pharmacist of CPIE, he has been instrumental in leading the business transformation from the current pharmacy manufacturing business to become a global medical device development, commercialisation and manufacturing business.

Over the past decade, Andrew has provided significant local and national leadership including as national board director of the Pharmaceutical Society of Australia and Australian Medicines Handbook.

Paul Crockett

Product and Market Advisor / Co-Founder

Paul has a long-standing history in sales, marketing and business development in the pharmaceutical industry with more than 20 years’ experience. He has also been a small business owner in the business and residential security industry.

Mr Crockett was employed by CPIE Pharmacy Services in the role of Commercial Relations Manager from 2011 until July 2016 where he gained extensive knowledge in the needs of users, customers and stakeholders in the infusion market. Paul was involved in many of the research and development activities that were being undertaken by CPIE.

Chris Harris BEc FAICD

Strategic and Financial Advisor / Co-Founder

Mr Harris has had considerable experience in the international biotechnical and healthcare sector, in both executive and non-executive directorships, including former CEO and Managing Director of FH Faulding, and Chairman of Argo Investments.

Chris brings extensive experience in IPO capital raising and roles in corporate acquisitions and mergers. Whilst Chair of biotech company EvoGenix, he was responsible for leading a significant capital raise which resulted in the subsequent $335m takeover and merger with US based Cephalon Inc.


Infusion Innovations Pty Ltd (ABN 75 154 756 715)  has adopted comprehensive systems of control and accountability as the basis for the administration of Corporate Governance.

The Board of the Company is committed to administering the policies and procedures with openness and integrity, pursuing the true spirit of Corporate Governance commensurate with the Company’s needs.

The Corporate Governance principles adopted establish the framework for how the Board carries out its duties and obligations.